Hodges Capital Management’s Boston Scientific BSX Stock Holding History

Hodges Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,100	Closed	-$327K	–	218
2020 Q4	$327K	Sell	9,100 -9,288	-51%	-$335K	0.05%	176
2020 Q3	$703K	Hold	18,388	–	–	0.14%	126
2020 Q2	$646K	Sell	18,388 -6,250	-25%	-$225K	0.13%	127
2020 Q1	$804K	Sell	24,638 -22,200	-47%	-$867K	0.21%	101
2019 Q4	$2.12M	Sell	46,838 -11,596	-20%	-$485K	0.28%	97
2019 Q3	$2.38M	Sell	58,434 -6,200	-10%	-$263K	0.27%	93
2019 Q2	$2.78M	Sell	64,634 -165,455	-72%	-$6.36M	0.3%	85
2019 Q1	$8.83M	Sell	230,089 -64,810	-22%	-$2.48M	0.89%	37
2018 Q4	$10.4M	Buy	294,899 +127,599	+76%	+$4.63M	1.17%	23
2018 Q3	$6.44M	Buy	+167,300	New	+$5.84M	0.47%	59
2013 Q4	–	Sell	-842,750	Closed	-$9.89M	–	238
2013 Q3	$9.89M	Buy	842,750 +175,000	+26%	+$1.89M	0.85%	47
2013 Q2	$6.19M	Buy	+667,750	New	+$5.66M	0.66%	64

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Hodges Capital Management's BSX Position: Q1 2021 in Review

Hodges Capital Management sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 9,100 shares — an estimated $327K sold.

Hodges Capital Management first reported a position in BSX in Q2 2013 and held it in 12 quarters. The position peaked at $10.4M in Q4 2018. 832 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

Hodges Capital Management reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
Hodges Capital Management sold 9,100 Boston Scientific shares in Q1 2021, an estimated $327K.
Hodges Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 12 quarters.
Hodges Capital Management's Boston Scientific position peaked at $10.4M in Q4 2018.
832 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Hodges Capital Management's 13F filing for Q1 2021, filed 7 Apr 2021.